Breast Implant-Associated ALCL: A Unique Entity in the Spectrum of CD30+ Lymphoproliferative Disorders

Oncologist - United States
doi 10.1634/theoncologist.2012-0238
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Single-Fraction Radiotherapy for CD30+Lymphoproliferative Disorders

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

SATB1 Defines a Subtype of Cutaneous CD30+ Lymphoproliferative Disorders Associated With a T-Helper-17 Cytokine Profile

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Specific Genetic Alterations Characterize Seroma- And Tumor-Type Breast-Implant Associated Anaplastic Large Cell Lymphoma (Bia-Alcl) as a Distinct Disease Entity

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

STAT3 Mutation Is Associated With STAT3 Activation in CD30+ ALK− ALCL

Cancers
Cancer ResearchOncology
2020English

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) — How to Diagnose and Treat?

Nowotwory
Cancer ResearchOncology
2018English

Soluble CD30: A Serum Marker for Epstein-Barr Virus-Associated Lymphoproliferative Diseases

Journal of Medical Virology
VirologyInfectious Diseases
2010English

Risk of Breast Implant Associated Anaplastic Large Cell Lymphoma (Bia-Alcl) in a Cohort of 3546 Women Prospectively Followed After Receiving Textured Breast Implants

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Endogenous Retroviral Elements, but Not Exogenous Retroviruses, Are Detected in CD30-positive Lymphoproliferative Disorders of the Skin

Carcinogenesis
MedicineCancer Research
2003English

CD5-positive Chronic B-Cell Lymphoproliferative Disorders: Diagnosis and Prognosis of a Heterogeneous Disease Entity

Cytometry Part B - Clinical Cytometry
Forensic MedicinePathologyHistologyCell Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy